Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  therapeutic hydrocortisone
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 188 for your search:
Start Over
Phase II/III Endocrine Therapy with AG/TMX/HC vs TMX Alone for Metastatic or Recurrent Breast Carcinoma, with AG/HC for Patients with Prior TMX
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: postmenopausal
Sponsor:
Protocol IDs: MAYO-803201
Phase II/III Pilot Study of Endocrine Therapy with Tamoxifen vs Tamoxifen plus Aminoglutethimide in Premenopausal Patients with Metastatic Breast Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 to 55
Sponsor: NCI
Protocol IDs: DFCI-79049, NCI-T84-0176D, T84-0176
Phase II/III Randomized Comparison of Up-Front Alternating Chemotherapy vs Up-Front Intensive 6-MP/MTX for Poor Prognosis Childhood ALL
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 1 to 20
Sponsor: NCI
Protocol IDs: POG-8698
Phase II/III Randomized Comparison of VP-16/AMSA vs VP-16/AMSA/AZC in Children with Refractory ANLL (Summary Last Modified 10/91)
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-8820
Phase III Randomized Study of Twice-Daily vs Standard Daily MP During Continuation Therapy in Children with Standard-Risk Acute Lymphocytic Leukemia: An ALinC #16 Study
Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 through 21 at diagnosis
Sponsor: NCI
Protocol IDs: POG-9405, POG-ALINC-16/SR
Phase III Randomized Double-Blind Study of SUR/HC vs Placebo/HC in Metastatic Hormone-Refractory Prostate Carcinoma with Painful Bone Metastases (Summary Last Modified 01/96)
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: any age
Sponsor: Pharmaceutical / Industry
Protocol IDs: PD-1003-01, NCI-V94-0598
Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 60
Sponsor: Other
Protocol IDs: EORTC-06951, FRE-LALA-94, NCT00002700
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
Phase: Phase III
Type: Treatment
Status: Completed
Age: 1 to 9
Sponsor: NCI, Other
Protocol IDs: 1952, CCG-1952, CDR0000064665, NCT00002744
TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: over 6 months to under 21
Sponsor: NCI, Other
Protocol IDs: 5961, COG-C5961, CCG-5961, SFOP-LMB-96, CCLG-NHL-9600, EU-96048, CDR0000064702, NCT00002757
Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: any age
Sponsor: NCI, Other
Protocol IDs: CDR0000064708, U10CA031946, CLB-9583, CALGB-9583, NCT00002760
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Phase: Phase III
Type: Treatment
Status: Completed
Age: Under 22
Sponsor: NCI
Protocol IDs: NCI-2012-01834, 2961, U10CA098543, CDR0000064883, COG-2961, CCG-2961, NCT00002798
Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia
Phase: Phase III
Type: Treatment
Status: Completed
Age: under 21
Sponsor: NCI, Other
Protocol IDs: 1951, CCG-1951, CDR0000064968, NCT00002816
Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI, Other
Protocol IDs: DM95-231, P30CA016672, MDA-DM-95231, NCI-G96-1044, CDR0000065105, NCT00002855
Phase III Randomized Study of Orchiectomy or LHRH Analogue Plus Flutamide With or Without Suramin and Hydrocortisone in Advanced Adenocarcinoma of the Prostate
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: E-8892, CLB-E8892, SWOG-E8892, NCT00002881, E8892
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 60
Sponsor: Other
Protocol IDs: SAKK 38/97, SWS-SAKK-38/97, EU-97037, NCT00003215
Combination Chemotherapy and Radiation Therapy in Treating Children With Acute Lymphoblastic Leukemia
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 1 to 17
Sponsor: NCI, Other
Protocol IDs: CDR0000066202, DFCI-95001, DFCI-FDR001197, NCI-G99-1651, NCT00004034
Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome
Phase: Phase III
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI, Other
Protocol IDs: A2971, COG-A2971, CCG-A2971, POG-A2971, CCG-29701, CDR0000066664, NCT00003593
Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: Under 18
Sponsor: Other
Protocol IDs: CDR0000066840, EORTC-58951, NCT00003728
Phase III Chemotherapy with POMP (6-MP/VCR/MTX/PRDL) vs 6-MP/MTX/PRED/CF/HC for Maintenance in Childhood Leukemia
Phase: Phase III
Type: Treatment
Status: Completed
Age: under 15
Sponsor: NCI
Protocol IDs: POG-7220/21
VCR/PRED, L-ASP/CTX/MTX/PRED/HC/ARA-C, 6-MP/MTX/PRED/HC/ARA-C/CF, VCR/PRED/ADR Chemotherapy & Radiotherapy for ALL, AUL or ASL
Phase: Phase III
Type: Treatment
Status: Completed
Age: under 18
Sponsor: NCI
Protocol IDs: POG-7420/21, MDAR-23, POG-ALINC-11
Start Over